高级检索
当前位置: 首页 > 详情页

Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

文献详情

资源类型:
Pubmed体系:
机构: [1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. [2]Hebei Yanda Lu Daopei Hospital, Langfang, Hebei & Beijing Lu Daopei Hospital, Beijing, China. [3]The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Disease, Soochow, China. [4]The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [5]State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. [6]Chinese PLA General Hospital, Beijing, China. [7]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. [8]Xinqiao Hospital of Army Medical University, Chongqing, China. [9]Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China. [10]Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fuzhou, China. [11]West China Hospital, Sichuan University, Chengdu, Sichuan, China. [12]The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. [13]Nanfang Hospital, Guangzhou, China. [14]Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. [15]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [16]Xiangya Hospital, Central South University, Changsha, Hunan, China. [17]Nanfang-Chunfu Children's Institute of Hematology, Taixin Hospital, Dongguan, China. [18]Shanghai Institute of Hematology, Ruijn Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [19]Shenzhen Children's Hospital, Shenzhen, Guangdong, China. [20]The First Affiliated Hospital of Guangxi Medical University, Nanning, China. [21]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. xjhrm@medmail.com.cn.
出处:
ISSN:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 移植 3 区 血液学 3 区 免疫学 3 区 肿瘤学
第一作者:
第一作者机构: [1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52808 今日访问量:0 总访问量:4561 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号